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 25 
ABSTRACT 26 
In this study, ibuprofen-loaded calcium alginate beads (CABs) with varying amounts of 27 
non-cross-linked calcium (NCL-Ca) were prepared using different washing methods. The 28 
influence of NCL-Ca on beads properties was investigated. Increasing the number or 29 
duration of washes led to significant decreases in the amount of NCL-Ca whereas the 30 
impact of the volume of washes was not significant. Approximately 70% of the initial 31 
amount of Ca
+2
 was NCL-Ca which was removable by washing while only 30% was 32 
cross-linked (CL-Ca). Ca
+2
 release from the CABs was bimodal; NCL-Ca was burst-33 
released followed by a slower release of CL-Ca. Washing methods and the amount of 34 
NCL-Ca had significant influences on the encapsulation efficiency, beads weight, beads 35 
swelling, drug release profile and the mucoadhesiveness of CABs. This study highlighted 36 
the importance of washing methods and the amount of NCL-Ca to establish CABs 37 
properties and understand their behaviour in the simulated intestinal fluids (SIFs).    38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
 47 
 48 
 49 
 50 
Keywords: Calcium alginate beads, cross-linked calcium, non-cross-linked calcium, 51 
encapsulation efficiency, mucoadhesiveness, drug release. 52 
 53 
1. Introduction  54 
 55 
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Alginates are natural, nontoxic and biodegradable polysaccharide polymers available 56 
in abundance from renewable sources (Tonnesen & Karlsen, 2002). Alginates form gel 57 
under mild environment in the presence of divalent cations such as Zn
+2
 or Ca
+2
 without 58 
the need for toxic reactants. Furthermore, alginates display very good muco- and 59 
bioadhesive properties prolonging their residence time in different mucosal tissues 60 
(Sosnik, 2014). Due to their unique properties and the gelation simplicity, alginates have 61 
been widely used in many pharmaceutical applications such as the development of 62 
mucoadhesive and controlled release delivery systems for drugs and proteins (Alipour, 63 
Montaseri & Tafaghodi, 2010, Azarnia, Lee, Robert & Champagne, 2008, Barzegar-64 
Jalaliet al., 2013, Gray & Dowsett, 1988, Iskenderoglu, Acarturk, Erdogan & Bardakci, 65 
2013, Jamstorp, Bodin, Gatenholm, Jeppsson & Stromme, 2010, Yanget al., 2013), the 66 
immobilization/encapsulation of cells for tissue engineering applications (Singh, Deol & 67 
Kaur, 2012, Xu, Xu, Wang, Ye, Zhou & Tan, 2014) and the bone regenerative medicine 68 
(Despanget al., 2013, Schutz, Despang, Lode & Gelinsky, 2014).  69 
Alginates are composed of 1–4 linked α-L-guluronic acid (G) and β-D-mannuronic acid 70 
(M) arranged alternately in homopolymeric blocks (poly-M and poly-G) and in mixed 71 
blocks (MG). The poly-G and the MG blocks are buckled while the poly-M blocks have a 72 
shape referred to as an extended ribbon (Giri, Thakur, Alexander, Ajazuddin, Badwaik & 73 
Tripathi, 2012, Sriamornsak, Thirawong & Korkerd, 2007). The cavities formed between 74 
two adjacent guluronates in the poly-G or MG blocks are of dimensions that are ideal for 75 
the cooperative binding of Ca
+2
 (George & Abraham, 2006). When a solution of sodium 76 
alginate is extruded into a solution of calcium chloride, Ca
+2
 diffuses into the alginate 77 
droplets. This causes the gelation of alginate and eventually the formation of CABs. 78 
Whilst in the cavities among the guluronates, Ca
+2
 cross-link with poly-G and/or MG 79 
blocks generating a gel with a characteristic structure known as an egg-box structure 80 
(Donati, Holtan, Morch, Borgogna, Dentini & Skjak-Braek, 2005, Morch, Donati, Strand 81 
& Skjak-Braek, 2006, Sriamornsak & Kennedy, 2008). Poly-M does not contribute to 82 
cross-linking with divalent ions (Morch, Donati, Strand & Skjak-Braek, 2006). Thus, the 83 
composition and block structure of alginates have an essential influence on both its 84 
gelation and ion-binding properties (Morch, Donati, Strand & Skjak-Braek, 2006).  85 
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Rich in guluronate residues, CABs have a higher extent of cross-linking and a lower 86 
release rate of encapsulated drug compared to that of fewer guluronate residues (Fathy, 87 
Safwat, el-Shanawany, Shawky Tous & Otagiri, 1998, Sriamornsak & Kennedy, 2006). 88 
The extent of alginate cross-linking is also influenced by the concentration of the cross-89 
linker solution and the curing time (Tateshita, Sugawara, Imai & Otagiri, 1993). In 90 
general, the higher the concentration of Ca
+2 
solution and/or the longer the duration of 91 
cross-linking process the greater is the extent of cross-linking, hence, slower drug release 92 
(Heng, Chan & Wong, 2003, Rajinikanth, Sankar & Mishra, 2003). The composition of 93 
the in vitro  release testing medium may also have a significant effect on the rate of drug 94 
release (Assifaoui, Chambin & Cayot, 2011). For example, release mediums containing 95 
chelating agents such as phosphate salts or high concentration of monovalent ions 96 
displace the cross-linkers, destabilize the beads and accelerate the drug release (Kim, 97 
Chung, Shin, Yam & Chung, 2008).  98 
The Ca
+2 
retained by CABs can be either CL-Ca  which is tightly cross-linked with poly-99 
G and MG blocks or NCL-Ca having a weak interaction with the poly-M blocks 100 
(Bourgeois, Gernet, Pradeau, Andremont & Fattal, 2006, Khoder, Tsapis, Huguet, 101 
Besnard, Gueutin & Fattal, 2009, Kikuchi, Kawabuchi, Watanabe, Sugihara, Sakurai & 102 
Okano, 1999). NCL-Ca is normally removable by a washing process whereas the CL-Ca 103 
is not washable (Bourgeois, Gernet, Pradeau, Andremont & Fattal, 2006, Khoder, Tsapis, 104 
Huguet, Besnard, Gueutin & Fattal, 2009). It is noteworthy that although the washing 105 
methods are of great importance during the preparation of CABs, there have been very 106 
little about it in literature. Furthermore, the influence of the NCL-Ca on the properties of 107 
CABs and the rate of drug release has not yet been profoundly investigated. Similarly, the 108 
influence of SIFs on the beads Ca
+2 
content and subsequently on the drug release profile 109 
has not been adequately studied. 110 
 111 
In this study, the preparation and characterisation of CABs containing different amount 112 
of NCL-Ca are described. The impact of washing procedures on CABs properties is 113 
investigated. And, to establish a validated method for drug release from CABs, beads 114 
mucoadhesiveness, beads swelling behaviour and drug release profile are studied in two 115 
different simulated intestinal fluids.116 
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 117 
2. Materials and methods  118 
2.1. Materials   119 
Sodium alginate extracted from Laminaria hyperborea with a MW of 1.97×105 and M/G 120 
ratio of 0.59 was purchased from BDH Chemicals Limited, UK. Ibuprofen (IBU), 121 
calcium chloride (CaCl2), eriochrome black T and ethylenediaminetetraacetic acid 122 
(EDTA) were supplied by Sigma-Aldrich, UK. Water was purified using automatic water 123 
still (SAWS-1008 Shin saeng scientific co. ltd, Korea). 124 
In order to investigate the impact of the composition of dissolution medium on the 125 
swelling and drug release behaviours from CABs, two different simulated intestinal fluids 126 
were freshly prepared as following: 127 
a) Simulated intestinal fluid based on phosphate buffer (SIFp): contained 99.93 128 
mmol KH2PO4 and 27.8 mmol NaOH. The pH was finally adjusted to 6.8 with 129 
NaOH 1 M.  130 
b) Simulated intestinal fluid based on maleate buffer (SIFm): 19.01 mmol Maleic 131 
acid, 34.8 mmol NaOH and 68.69 mmol NaCl. The pH was adjusted to 6.8 with 132 
NaOH 1 M. 133 
2.2. Preparation of CABs 134 
CABs loaded with IBU were prepared by ionotropic gelation using CaCl2 as a cross-135 
linker. Briefly, 3 g of SA was dissolved in 100 mL of deionized water and 2 g of IBU 136 
were added to the alginate solution and thoroughly with a stirrer to form a viscous coarse 137 
dispersion. Six (6) mL of the resulting bubble-free dispersion was then dropped using a 138 
pump-connected syringe into 60 mL of 10% w/v CaCl2 solution kept under a gentle 139 
agitation. Beads were allowed to stand in CaCl2 solution for 30 min before being 140 
collected and washed. Washing process involved soaking the freshly prepared beads in 141 
deionized water with magnetic stirring at 300 rpm. Three washing protocols where 142 
adopted; (i) beads were washed for a minute in 60 mL deionised water and the number of 143 
washes was increased from 0 to 8 times. Formulations obtained by this protocol were 144 
named according to the number of washings (N1, N2, N3, N4, N5, N6, N7 and N8). In 145 
the second protocol, (ii) beads were washed one time in 60 mL deionised water for 1, 4 or 146 
8 minutes. In the third, (iii) beads were washed one time for one minute in 60, 120 or 180 147 
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mL deionised water. All collected beads were finally dried in an air convection type oven 148 
(Memmert, Germany) at a temperature of 40°C for 48h (Khoder, Tsapis, Domergue-149 
Dupont, Gueutin & Fattal, 2010, Sriamornsak & Kennedy, 2006). 150 
 151 
2.3. Weight uniformity testing 152 
To determine beads average weight, 20 beads were randomly sampled and accurately 153 
weighed using Precisa scale 320 XB balance (220A, Switzerland). The results were 154 
expressed as mean values ± standard deviation of 20 determinations. 155 
 156 
2.4. Encapsulation efficiency (EE) 157 
Five beads were placed in a beaker containing 100 mL of the SIFm for 48h to allow their 158 
complete dissolution. Samples were then taken, filtered and the amount of released IBU 159 
was analysed by UV spectroscopy (SP-3000 Plus, Optima, Japan) at 264 nm. The EE was 160 
determined according to the formula:  161 
  162 
where  is the amount of drug measured in five dried beads and  is the initial 163 
amount of drug dispersed in the alginate solution required to form five beads. 164 
 165 
2.5. Scanning electron microscopy  166 
Scanning electron microscopy (SEM) images of the typical external structure of the dried 167 
beads N1 before and after their incubation for 2h in either SIFm or SIFp were obtained 168 
using FEI Quanta 200 microscope  (FEI company, Hillsboro, OR, USA) operated at an 169 
accelerating voltage of 30 kV under low-vacuum mode.  170 
 171 
2.6. Fourier transform infrared analysis 172 
Fourier Transform Infrared (FT-IR) measurements of SA, IBU and IBU-loaded CABs 173 
were performed using an FT-IR spectrometer (Thermo Scientific Nicolet 128 is5, Thermo 174 
fisher, Madison, USA). The spectra were acquired over the wavenumber range of 4000 to 175 
500 cm
−1
 at ambient temperature. 176 
 177 
2.7. X-ray diffraction 178 
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The precipitate created during the swelling and dissolution studies in SIFp was collected, 179 
washed three times with deionized water and dried at 105°C for 5h. The precipitate was 180 
then exanimated by X-ray diffraction through Bruker SMART CCD area-detector 181 
diffractometer (Bruker AXS, Germany).  182 
 183 
2.8. Determination of Ca
+2
 content 184 
To determine the total amount of Ca
+2 
retained by beads, five beads were weighed and 185 
placed in a beaker containing 100 mL of SIFm. After 48h, samples were taken and the 186 
amount of Ca
+2
 was determined by the complexometric titration method using EDTA 187 
solution and eriochrome black–T indicator (Lindstrom & Diehl, 1960). The same method 188 
was adopted to determine the release kinetics of Ca
+2 
from CABs N1 and N7 in SIFm. 189 
The amount of released Ca
+2 
was determined at time intervals of (5, 10, 15, 30, 60 and 190 
120 min).  191 
 192 
2.9. Beads swelling and drug release studies 193 
Swelling and release studies were carried out on the CABs N1 and N7 in both SIFm and 194 
SIFp using a USP rotating basket apparatus (ERWEKA DT 600 HH, Germany) at 100 195 
rpm and 37°C. In each experiment, 40 beads were weighed and placed in the apparatus 196 
vessel containing 400 mL of the swelling or the dissolution medium. For the swelling 197 
study, beads were carefully taken out at time intervals, drained with filter paper to 198 
remove excess water and weighted. Weight changes were calculated using the following 199 
equation: 200 
 201 
Where Wt is the weight of beads at a tested time and Wd is the weight of dry beads. 202 
In a separate experiment, samples of tested medium were withdrawn at the same time 203 
intervals, filtered and the released amount of IBU was determined by UV spectroscopy 204 
(SP-3000 Plus, Optima) at 264 nm. 205 
 206 
2.10. Mucoadhesion testing 207 
The mucoadhesiveness of the CABs N1 and N7 in the SIFm were evaluated by in vitro 208 
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wash-off method (Lehr, Bouwstra, Schacht & Junginger, 1992, Prajapati, Tripathi, 209 
Ubaidulla & Anand, 2008). Briefly, freshly excised pieces of sheep intestinal mucosa (2 210 
cm × 2 cm) collected from a slaughter house were mounted on glass slides (7.5 × 2.5 cm) 211 
using thread. 25 beads were spread onto each wet piece of mucosa and immediately hung 212 
onto the arm of a USP tablet disintegration tester. The tissue specimens were given 213 
regular up and down movements in a vessel containing 900 mL of SIFm kept at 37°C. At 214 
hourly intervals up to 4 hours, the machine was stopped and the number of beads still 215 
adhering onto the tissue was counted. Percent mucoadhesion was given by the following 216 
formula. 217 
% adhesive strength = (no. of beads remains / no. of applied microspheres) ×100 218 
2.11. Statistical analysis  219 
Statistical significance was measured using the one-way analysis of variance (ANOVA) 220 
and student’s t-tests as appropriate. All values were expressed as the mean ± standard 221 
deviation. Values of P < 0.05 were regarded as significantly different. 222 
223 
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 224 
3. Results and discussion 225 
3.1. Preparation of CABs 226 
IBU-loaded CABs were prepared by ionotropic gelation method. All formulations were 227 
allowed to develop the same extent of cross-linking by fixing the polymer/drug ratio at 228 
(3:2), the concentration of CaCl2 solution at (10% w/v) and the cross-linking time at (30 229 
min). According to Sriamornsak et al (2008), 20 minutes is the minimum time needed for 230 
complete beads formation by ionotropic gelation. The concentration of CaCl2 solution 231 
used in this study (10% w/v ~ 0.9 M) is considerably higher than the minimum 232 
concentration of counter ions needed to form beads which is in the low millimolar range 233 
(Chuehet al., 2010). This high concentration of cross-linker solution was used in order to 234 
allow a high degree of cross-linking as well as high entrapment of NCL-Ca. Before the 235 
drying step, the fresh beads were washed using different washing protocols; 236 
hypothetically, varying washing protocols might remove different amounts of NCL-Ca 237 
from the beads whereas CL-Ca is not removable by washing processes (Bourgeois, 238 
Gernet, Pradeau, Andremont & Fattal, 2006, Khoder, Tsapis, Huguet, Besnard, Gueutin 239 
& Fattal, 2009). Therefore, the obtained beads should have the same extent of cross-240 
linking but different amount of NCL-Ca.  241 
Obtained beads were spherical and homogenous regardless of the washing method (Fig. 242 
1a). Scanning electron micrographs of CABs N1 showed relatively rough surfaces with 243 
few small crystals probably due to partially crystallized IBU formed during the drying 244 
step (Fig. 1b). This hypothesis is supported by the high encapsulation efficiency (93.3%) 245 
(Fig. 4a) and by the disappearance of these crystals after 2 h of incubation in the SIFm 246 
(Fig. 1c); corresponding to the release of 30% of the loaded IBU (Fig. 5d).  247 
Page 10 of 27
Ac
ce
pte
d M
an
us
cri
pt
10 
 
 248 
Fig.1. SEM images of  (a) dried IBU-loaded CABs N1 (scale bar = 1 mm), (b) the surface 249 
of IBU-loaded CABs N1 (scale bar = 500 µm), (c) the surface IBU-loaded CABs N1 250 
after 2 h of incubation in SIFm (scale bar = 400 µm) and (d) the surface IBU-loaded 251 
CABs N1 after 2 h of incubation in SIFp (scale bar = 200 µm). X-ray diffractogram of 252 
the precipitates formed on the surface of CABs N1 in the SIFp. 253 
 254 
3.2. FTIR spectroscopy 255 
Fig. 2 shows the FTIR spectra of SA, IBU and IBU-loaded CABs N1. FTIR spectrum of 256 
SA shows a wide absorption bands at 3255 cm
−1
 indicating the stretching of O−H and 257 
sharp absorption bands at 1595, 1405 and 1025 cm
−1 representing COO− (asymmetric), 258 
COO− (symmetric) and C−O−C, respectively (Fig. 2A). FTIR spectrum of IBU 259 
demonstrates characteristic peaks at 1708 cm‐1 and 2920 cm‐1 (Fig. 2B), representing the 260 
carbonyl and hydroxyl stretching respectively. Similar IR spectra of SA and IBU have 261 
been previously reported in the literature (Jabeen, Chat, Maswal, Ashraf, Rather & Dar, 262 
2015, Setty, Sahoo & Sa, 2005, Velascoet al., 2011). IBU-loaded CAB spectrum shows 263 
almost the same characteristic bands observed in the spectrum of free IBU (Fig. 2C). 264 
These results confirm that the IBU did not undergo any chemical reaction during the 265 
beads preparation. Additionally, the absorption region of stretching vibrations of O–H 266 
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bonds of alginate in CABs appeared narrower and smaller than that of SA (Fig. 2C and 267 
2A). Daemi and Barikani (2012) observed a similar difference in calcium alginate 268 
nanoparticles. They attributed this difference to the participation of hydroxyl and 269 
carboxylate groups of alginate with Ca
+2
 in the formation of egg-box structure and a 270 
consequent decrease in hydrogen bonding between hydroxyl functional groups; this 271 
affords a narrow O–H stretching band in calcium alginate (Daemi & Barikani, 2012). 272 
Similarly, the intensity of alginate peaks corresponding to COO− (asymmetric and 273 
symmetric) and C−O−C decreased significantly after their crosslinking with Ca+2. This 274 
might be attributed to the low percentage ion-bonding of Ca
+2
 relative to Na
+
 275 
(Papageorgiou, Katsaros, Kouvelos, Nolan, Le Deit & Kanellopoulos, 2006).  276 
 277 
Fig. 2. FTIR spectra of (A) SA, (B) IBU, and (C) IBU-loaded CABs N1. 278 
 279 
3.3. Determination of the amount of Ca
+2 
retained by beads
 
280 
Fig. 3 shows that increasing the number and the duration of washes had a significant 281 
influence on beads Ca
+2
 content (Fig. 3a and 3b). However, the impact of increasing the 282 
volume of washes was less significant (Fig. 3c). Interestingly, increasing the number of 283 
washes was able to remove an additional amount of Ca
+2 
until the sixth wash (P < 0.05). 284 
Afterward, washing had no significant impact on the amount of Ca
+2
 (Fig. 3a). This 285 
finding is in agreement with the other research findings reported in literature (Bourgeois, 286 
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Gernet, Pradeau, Andremont & Fattal, 2006, Khoder, Tsapis, Domergue-Dupont, Gueutin 287 
& Fattal, 2010, Khoder, Tsapis, Huguet, Besnard, Gueutin & Fattal, 2009). This result 288 
indicates that the Ca
+2 
remained within the beads after the sixth wash was already cross-289 
linked, i.e. non-washable CL-Ca. Accordingly, approximately 70% of the initial Ca
+2
 290 
content is NCL-Ca and less than 30%  is CL-Ca, i.e. all Ca
+2 
retained in beads N7, N6 291 
and N8 (Fig. 3a). To confirm these results, the release kinetic of Ca
+2
 from beads was 292 
also studied (Fig. 3d and 3e). According to Kikuchi et al and others, Ca
+2 
release from 293 
CABs was bimodal; NCL-Ca is firstly released followed by the release of CL-Ca 294 
(Alvarez-Lorenzo, Blanco-Fernandez, Puga & Concheiro, 2013, Kikuchi, Kawabuchi, 295 
Watanabe, Sugihara, Sakurai & Okano, 1999). Similarly, Fig. 3 shows that Ca
+2
 release 296 
from CABs N1 was bimodal with the first phase releasing approximately 75% of total 297 
Ca
+2
 (Fig. 3d). On the other hand, the release profile of Ca
+2 
from CABs N7 was 298 
monomodal (Fig. 3e), which is expected according to Fig. 4a as all Ca
+2 
remained in the 299 
beads N7 are cross-linked.  300 
 301 
Fig. 3. Ca
+2 
content in CABs (mg Ca / bead) as a function of (a) number, (b) duration and 302 
(c) volume of washes (n=3 ± SD). Figures (d) and (e) represent the cumulative release of 303 
Ca
+2
 plotted against the square root of time from CABs N1 in SIFm and in SIFm 304 
respectively (n=3 ± SD). 305 
 306 
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3.4. Encapsulation efficiency (EE) 307 
The EE is significantly affected by the washing process (Fig. 4a and 4b). As washing 308 
increases in term of number and duration, an additional and significant amount (p < 0.05) 309 
of loaded drug is removed from the beads. Since the loaded drug did not undergo any 310 
chemical covalent linking inside the beads (IR results), the amount of encapsulated IBU 311 
was descending during the 8 washes. Similar findings were reported relating to the effect 312 
of beads curing time in the gelation medium on the drug EE. On the other hand, the 313 
impact of the washing volume on the EE was less significant (p > 0.05) (data not shown); 314 
this is probably due to the sink conditions being attained with the smallest volume of 315 
washing (i.e. 60 mL). 316 
 317 
Fig.  4. Encapsulation efficiency of IBU in CABs as a function of (a) number and (b) 318 
duration of washes (n=3 ± SD). Figures (c) and (d) represent the average weight of dry 319 
CABs as a function of number and duration of washes respectively (n=3 ± SD).  320 
 321 
 3.5. Impact of the NCL-Ca on the weights of dry beads 322 
The washing process and the amount of NCL-Ca retained by beads have a significant 323 
impact on the weight of dry CABs. As shown in Fig. 4, beads weight decreased 324 
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significantly as the number and the duration of washes increased (P < 0.05) (Fig. 4c and 325 
4d). In contrast, increasing the volume of washes had a less significant effect on beads 326 
weight especially when the volume of washing exceeded 120 mL (data not shown). 327 
Interestingly, the changes in beads weight were consistent with Ca
+2 
content results; this 328 
might be explained by the hygroscopic properties of the Ca
+2 
which led to the 329 
corresponding increases in the water contents of the beads.  330 
 331 
3.6. Impact of NCL-Ca on the beads swelling in SIFs 332 
Fig. 5 shows the swelling profile of the beads N1 and N7 in the SIFp (Fig. 5a) and SIFm 333 
(Fig. 5b). In both media, CABs N7 swelled more than CABs N1. However, each bead 334 
showed dissimilar swelling profiles in both media. For example, beads N7 swelled twice 335 
as much in the SIFp (3800% after 240 min) compared with the SIFm (1915% after 240 336 
min). In contrast, the swelling extent of CABs N1 was significantly lower in the SIFp 337 
than that in the SIFm. Swelling process lasted 6 h for SIFm and 4 h for SIFp after which 338 
the beads started to lose their integrity and overall weight. Accordingly, SEM shows a 339 
formation of condense layer of crystals on the surface of CABs N1 (dried after incubation 340 
of 2 h in SIFp) (Fig. 1d), whereas no crystals were observed after incubating the same 341 
beads for the same time in the SIFm (Fig. 1c). Comparable swelling behaviors of calcium 342 
polysaccharide gels in different SIFs were previously reported elsewhere (Assifaoui, 343 
Chambin & Cayot, 2011, Sriamornsak & Kennedy, 2008). Apparently, when CABs are 344 
placed in a medium containing monovalent electrolytes, e.g. SIFs, Ca
+2
 are exchanged 345 
with monovalent ions (Khoder, Tsapis, Huguet, Besnard, Gueutin & Fattal, 2009, Kim, 346 
Chung, Shin, Yam & Chung, 2008). Therefore, when the beads contain only CL-Ca, e.g. 347 
beads N7, cross-linker ions are removed and beads swell rapidly. However, in case of N1, 348 
NCL-Ca replenishes CL-Ca during the initial stages of ions exchanging with monovalent 349 
cations, hence, protects the egg-box structure and decelerates swelling. Phosphate salts 350 
play the role of chelating agent and promotes Ca
+2 
extraction from beads (Lee & Min, 351 
1996). However, extracted Ca
+2 
could react with phosphate ions and precipitate on beads 352 
surface (Assifaoui, Chambin & Cayot, 2011). Accordingly, Ca
+2
 content of CABs N1 353 
were high enough to generate a condense layer of calcium phosphate precipitated on 354 
beads surface as shown by the SEM results (Fig. 1d). This layer plays a protective role 355 
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preventing the beads from further swelling. On the other hand, CABs N7, containing a 356 
limited amount of Ca
+2
, swelled then disintegrated as no the protective layer of calcium 357 
phosphate were formed on the beads surface. This is confirmed by X-ray diffraction 358 
analysis of the precipitate formed on the surface of CABs N1 during the incubation in 359 
SIFp (Fig. 1 supplementary information) as all the principal peaks identified on the 360 
precipitate XRD pattern were identical to those of dicalcium phosphate (the monetite - 361 
CaHPO4) (Tas, 2009). 362 
 363 
Fig. 5. Figures (a) and (b) represent the swelling profiles of CABs N1 and N7 in SIFp 364 
and SIFm respectively (n=3 ± SD). Figures (c) and (d) represent IBU release profiles 365 
from CABs N1 and CABs N7 in SIFp and SIFm respectively (n=3 ± SD).  366 
        367 
3.7. Impact of NCL-Ca on the drug release in SIFs 368 
Fig. 5 shows the cumulative release of IBU from CABs N1 and N7 in both SIFm (Fig. 369 
5c) and SIFm (Fig. 5d). IBU release from CABs N1 in the SIFm was significantly faster 370 
than that from CABs N7 (Fig. 5d). However, there were no significant differences 371 
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between the drug release profiles of both CABs N1 and N7 in SIFp during the first 3 372 
hours of the dissolution test (P > 0.05) (Fig. 5c). Thereafter, drug release profile of CABs 373 
N7 became significantly faster than that of CABs N1 (P < 0.05) (Fig. 5c). Drug release 374 
from CABs is mainly controlled by swelling and/or drug diffusion through the swollen 375 
polysaccharide matrix (Siepmann & Siepmann, 2012). Beads degradation may also 376 
hasten drug release rate, particularly in late stages of the release. Swollen Alginate beads 377 
possess pores with approximately 5 to 200 nm diameters, which is definitely larger than 378 
the dimension of IBU molecules (0.5 × 1.2 × 0.8 nm) (Hillerstrom, van Stam & 379 
Andersson, 2009, Inger-Lill, Olav, Olav, Kjetill & Per Chr, 1977, Otterlei, Ostgaard, 380 
Skjak-Braek, Smidsrod, Soon-Shiong & Espevik, 1991, Tanaka, Matsumura & Veliky, 381 
1984). Therefore, the release of IBU through alginate beads might not be controlled by 382 
diffusion rather than the rate of swelling process; thus, the degradation of beads. Beads 383 
swelling increases the diffusion pathway and this reduces the drug-concentration gradient 384 
and decreases the drug-release rate (Siepmann & Siepmann, 2012). In correspondence to 385 
bead swelling results (Fig. 5a and 5b), IBU release in SIFm from CABs N7 was slower 386 
than that of CABs N1 the least swollen bead (Fig. 5d). In contrast, using SIFp, IBU 387 
release from beads N7 increased dramatically after 3 h (Fig. 5c), the beginning of beads 388 
disintegration (Fig. 5a). Therefore, IBU release from CABs N7 in SIFp is suggested to be 389 
predominantly governed the erosion and disintegration of these beads after 3 h of 390 
incubation.  On the other hand, the protective layer of the dicalcium phosphate precipitate 391 
formed on the surface of the CABs N1 slows down the drug release in SIFp during the 392 
same period of time. These results highlight the importance of the composition of SIFs 393 
for drug release studies. Phosphate buffer is mainly used in the SIFs thanks to its high 394 
buffering capacity. However, phosphate buffer is not bio-relevant and do not simulate the 395 
composition and the ionic strength of biological fluids (Alhnan, Kidia & Basit, 2011, 396 
Fadda, Merchant, Arafat & Basit, 2009). Therefore, and in correspondence with our 397 
results, alternative buffers, such as bicarbonate, maleate or acetate buffer, have been 398 
suggested for dissolution studies (Alhnan, Kidia & Basit, 2011, Boni, Brickl & 399 
Dressman, 2007, Fadda, Merchant, Arafat & Basit, 2009).  400 
 401 
3.8. Impact of NCL-Ca on CABs mucoadhesiveness in SIFm 402 
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Fig. 6 shows the wash-off behaviour of CABs N1 and N7 performed in SIFm. The results 403 
show the percent of beads remained adhering to the intestine per time (min). The 404 
mucoadhesiveness was significantly different for both CABs. CABs N7 display a higher 405 
mucoadhesiveness with 48±6.9% of beads remained adherent on the mucosal tissue after 406 
2 h of the wash-off test. Comparable mucoadhesion properties of CABs were previously 407 
reported in the literature (Adebisi, Laity & Conway, 2015, Veerareddy, Tedla, Banda, 408 
Bandari & Jukanti, 2011). On the other hand, only 6.6±4.6% of CABs N1 were still 409 
adhered on the mucosal tissue after the same period (Fig. 6). 410 
 411 
Fig.6. Mucoadhesion of CABs N1 and CABs N7 in SIFm (n=3 ± SD). 412 
The mucoadhesiveness of alginate is mainly related to the ability of carboxylic groups to 413 
form hydrogen-bonds with oligosaccharide chains of mucins (Khutoryanskiy, 2011). 414 
Indeed, the difference in the mucoadhesion behaviour of CABs N1 and N7 might be 415 
explained by the difference in the Ca
+2
 contents of these two formulations (Fig. 3a). It is 416 
well known that Ca
+2
 decreases the viscosity of mucus and may collapse entirely the 417 
mucin gel (Forstner & Forstner, 1976, Lai, Wang, Wirtz & Hanes, 2009, Raynal, 418 
Hardingham, Sheehan & Thornton, 2003). Decreasing the mucus viscosity would have a 419 
direct and negative impact on the mucoadhesion properties of CABs as the mucus layer 420 
with lower viscosity promotes weaker retention ability and less available groups for 421 
interactions with alginate.  422 
 423 
 424 
 425 
 426 
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 427 
 428 
 429 
 430 
 431 
 432 
4. Conclusion 433 
In this study, IBU-loaded CABs with the same degree of crosslinking and different 434 
amounts of NCL-Ca were prepared in order to investigate the influence of NCL-Ca on 435 
beads properties and the drug release profiles in SIFs. This study showed that the 436 
washing step, often neglected by researchers, had a significant impact on the amount 437 
NCL-Ca retained by CABs. The washing process in term of number or duration 438 
significantly influenced the amount of NCL-Ca retained by beads; hence the beads 439 
properties such as EE, mucoadhesiveness, swelling nd drug release in SIFs. These 440 
results highlight the importance of washing step and the amount of NCL-Ca when 441 
developing calcium alginate-based drug delivery systems. This study showed also that the 442 
composition of the SIFs is of great significance in order to perform reliable and consistent 443 
swelling and release studies.     444 
 445 
 446 
 447 
 448 
 449 
 450 
 451 
 452 
 453 
 454 
 455 
 456 
 457 
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 Calcium alginate beads with different amounts of Ca+2 were prepared. 623 
 Beads washing resulted in removing non-cross-linked Ca+2 (NCL-Ca) only. 624 
 Ca+2 release was bimodal; NCL-Ca was burst-released followed by CL-Ca 625 
release. 626 
 NCL-Ca had a significant impact on bead swelling and drug release in SIFs. 627 
 NCL-Ca had a significant impact on the mucoadhesive properties of beads. 628 
 629 
 630 
 631 
 632 
 633 
Supplementary Information 634 
 635 
 636 
Figure 1: X-ray diffractgram of the precipitates formed on the surface of CABs N1 in the 637 
SIFp. 638 
All the principal peaks identified on the X-ray diffractgram of the precipitate formed on 639 
the surface of CABs N1 in the SIFp are identical to those of dicalcium phosphate (the 640 
monetite - CaHPO4) (Tas, 2009). 641 
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